Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2560

1.

The impact of short and long sleep duration on instrumental activities of daily living among stroke survivors.

Seixas AA, Chung DP, Richards SL, Madhavaram S, Raghavan P, Gago J, Casimir G, Jean-Louis G.

Neuropsychiatr Dis Treat. 2019 Jan 4;15:177-182. doi: 10.2147/NDT.S177527. eCollection 2019.

2.

Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment.

Albai O, Frandes M, Timar R, Roman D, Timar B.

Neuropsychiatr Dis Treat. 2019 Jan 3;15:167-175. doi: 10.2147/NDT.S189905. eCollection 2019.

3.

Risk factors for the difficulties in general activities across the day in Chinese children and adolescents with attention-deficit/hyperactivity disorder.

Ke X, Du Y, Zheng Y, Su L, Chen Y, Zhang Y, Chen K, Cheng Y, Chen W.

Neuropsychiatr Dis Treat. 2018 Dec 31;15:157-166. doi: 10.2147/NDT.S187882. eCollection 2019.

4.

Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis.

Xu FL, Wang BJ, Yao J.

Neuropsychiatr Dis Treat. 2018 Dec 28;15:143-155. doi: 10.2147/NDT.S190563. eCollection 2019.

5.

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff.

Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N.

Neuropsychiatr Dis Treat. 2018 Dec 27;15:137-142. doi: 10.2147/NDT.S185483. eCollection 2019.

6.

Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis.

Ghaffarpasand F, Torabi S, Rasti A, Niakan MH, Aghabaklou S, Pakzad F, Beheshtian MS, Tabrizi R.

Neuropsychiatr Dis Treat. 2018 Dec 27;15:127-135. doi: 10.2147/NDT.S186865. eCollection 2019.

7.

Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning.

Carmassi C, Dell'Oste V, Ceresoli D, Moscardini S, Bianchi E, Landi R, Massimetti G, Nisita C, Dell'Osso L.

Neuropsychiatr Dis Treat. 2018 Dec 24;15:115-125. doi: 10.2147/NDT.S179013. eCollection 2019.

8.

A literature-based algorithm for the assessment, management, and monitoring of drug-induced QTc prolongation in the psychiatric population.

Zolezzi M, Cheung L.

Neuropsychiatr Dis Treat. 2018 Dec 24;15:105-114. doi: 10.2147/NDT.S186474. eCollection 2019. Review.

9.

Poststroke epilepsy: current perspectives on diagnosis and treatment.

Sarecka-Hujar B, Kopyta I.

Neuropsychiatr Dis Treat. 2018 Dec 24;15:95-103. doi: 10.2147/NDT.S169579. eCollection 2019. Review.

10.

Associations of BRAP polymorphisms with the risk of alcohol dependence and scores on the Alcohol Use Disorders Identification Test.

Kim JW, Choe YM, Shin JG, Park BL, Shin HD, Choi IG, Lee BC.

Neuropsychiatr Dis Treat. 2018 Dec 24;15:83-94. doi: 10.2147/NDT.S184067. eCollection 2019.

11.

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder.

Brown EC, Clark DL, Hassel S, MacQueen G, Ramasubbu R.

Neuropsychiatr Dis Treat. 2018 Dec 21;15:75-82. doi: 10.2147/NDT.S184425. eCollection 2019.

12.

Treatment of acute thromboembolic complication after stent-assisted coil embolization of ruptured intracranial aneurysm: a case report.

Xu N, Meng H, Liu T, Feng Y, Qi Y, Wang H.

Neuropsychiatr Dis Treat. 2018 Dec 21;15:69-74. doi: 10.2147/NDT.S184372. eCollection 2019.

13.

The factor structure, reliability and validity of the Chinese version of the Van Dream Anxiety Scale.

Wang X, Dai L, Yin M, Deng Y.

Neuropsychiatr Dis Treat. 2018 Dec 21;15:57-67. doi: 10.2147/NDT.S192891. eCollection 2019.

14.

Association between CD14 rs2569190 C>T polymorphism and ischemic stroke susceptibility: a meta-analysis based on 5,277 subjects.

Wu YQ, Cheng SY, Xu XC, Li WC.

Neuropsychiatr Dis Treat. 2018 Dec 21;15:47-55. doi: 10.2147/NDT.S185313. eCollection 2019.

15.

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies.

Thase ME, Weiller E, Zhang P, Weiss C, McIntyre RS.

Neuropsychiatr Dis Treat. 2018 Dec 20;15:37-45. doi: 10.2147/NDT.S185815. eCollection 2019.

16.

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm.

Dong H, Fan S, Luo Y, Peng B.

Neuropsychiatr Dis Treat. 2018 Dec 19;15:33-36. doi: 10.2147/NDT.S181820. eCollection 2019.

17.

Influence of Xiaoyaosan on depressive-like behaviors in chronic stress-depressed rats through regulating tryptophan metabolism in hippocampus.

Jiao H, Yan Z, Ma Q, Li X, Jiang Y, Liu Y, Chen J.

Neuropsychiatr Dis Treat. 2018 Dec 18;15:21-31. doi: 10.2147/NDT.S185295. eCollection 2019.

18.

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles.

Yi ZM, -, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD.

Neuropsychiatr Dis Treat. 2018 Dec 17;15:1-19. doi: 10.2147/NDT.S181886. eCollection 2019.

19.
20.

Activation of IL-8 and its participation in cancer in schizophrenia patients: new evidence for the autoimmune hypothesis of schizophrenia.

Xu L, Qi X, Zhu C, Wan L.

Neuropsychiatr Dis Treat. 2018 Dec 13;14:3393-3403. doi: 10.2147/NDT.S188210. eCollection 2018.

Supplemental Content

Loading ...
Support Center